Who
Michael Myers
Chief Executive Officer
Company insider
Files Form 4 as: Chief Executive Officer, Quoin Pharmaceuticals.
In numbers
- Trades disclosed
- 17
- Buys
- 4
- Sells
- 0
- Bought
- $479K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 26 Oct 2023
- Last trade
- 31 Aug 2026
- Last filed
- 1 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 1 Sep 2026 | QNRX Quoin PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $100K20,490 at $4.88 | filing |
| 31 Aug 2026filed 1 Sep 2026 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —10,245 | filing |
| 31 Aug 2026filed 1 Sep 2026 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —10,245 | filing |
| 31 Aug 2026filed 1 Sep 2026 | QNRX Quoin PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $100K20,490 at $4.88 | filing |
| 4 Feb 2026filed 6 Feb 2026 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —318,750 at $0.00 | filing |
| 4 Feb 2026filed 6 Feb 2026 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —318,750 at $0.00 | filing |
| 29 May 2025filed 13 Jun 2025 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —42,857 at $0.00 | filing |
| 29 May 2025filed 2 Jun 2025 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —42,039 at $0.00 | filing |
| 23 Dec 2024filed 27 Dec 2024 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —555,556 | filing |
| 23 Dec 2024filed 27 Dec 2024 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code P | —555,556 | filing |
| 23 Dec 2024filed 27 Dec 2024 | QNRX Quoin PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $250K555,556 at $0.45 | filing |
| 9 Dec 2024filed 10 Dec 2024 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —536,603 at $0.00 | filing |
| 4 Sep 2024filed 5 Sep 2024 | QNRX Quoin PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $3,5135,322 at $0.66 | filing |
| 4 Sep 2024filed 5 Sep 2024 | QNRX Quoin PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $6,1508,200 at $0.75 | filing |
| 4 Sep 2024filed 5 Sep 2024 | QNRX Quoin PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $19K23,572 at $0.80 | filing |
| 3 Sep 2024filed 5 Sep 2024 | QNRX Quoin PharmaceuticalsBiotechnology | SEC FORM 4 Bought | $496800 at $0.62 | filing |
| 26 Oct 2023filed 30 Oct 2023 | QNRX Quoin Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —80,965 at $0.00 | filing |
News
A giant Michael Myers is now presiding over South Pasadena, aka Haddonfieldnbclosangeles.com · 23 Oct 2026Man in Michael Myers Mask Arrested Over Inside Job Robberyusmagazine.com · 25 Sep 2026Florida store robbery with gunman in Michael Myers mask was 'inside job,' cops sayaol.com · 25 Sep 2026Suspect in Michael Myers mask accused of robbing Inverness liquor store, 2 arrestedfox13news.com · 24 Sep 2026Famous Actors Face Used For Michael Myers Mask | HuffPost UK Entertainmenthuffingtonpost.co.uk · 12 Sep 2026Quoin Pharmaceuticals (NASDAQ:QNRX) Stock Rating Raised to "Sell" at Wall Street ZenQNRX · dailypolitical.com · 18 Oct 2026
5 headlines in the last 90 days name Michael Myers; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.